-
1
-
-
0033519542
-
Elevated endogenous cannabinoids in schizophrenia
-
Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D. Elevated endogenous cannabinoids in schizophrenia. Neuroreport 1999; 10: 1665-9. (Pubitemid 29354290)
-
(1999)
NeuroReport
, vol.10
, Issue.8
, pp. 1665-1669
-
-
Leweke, F.M.1
Giuffrida, A.2
Wurster, U.3
Emrich, H.M.4
Piomelli, D.5
-
2
-
-
8444242207
-
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
-
DOI 10.1038/sj.npp.1300558
-
Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, et al. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 2004; 29: 2108-14. (Pubitemid 39486563)
-
(2004)
Neuropsychopharmacology
, vol.29
, Issue.11
, pp. 2108-2114
-
-
Giuffrida, A.1
Leweke, F.M.2
Gerth, C.W.3
Schreiber, D.4
Koethe, D.5
Faulhaber, J.6
Klosterkotter, J.7
Piomelli, D.8
-
3
-
-
64149127015
-
Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
-
Koethe D, Giuffrida A, Schreiber D, Hellmich M, Schultze-Lutter F, Ruhrmann S, et al. Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis. Br J Psychiatry 2009; 194: 371-2.
-
(2009)
Br J Psychiatry
, vol.194
, pp. 371-372
-
-
Koethe, D.1
Giuffrida, A.2
Schreiber, D.3
Hellmich, M.4
Schultze-Lutter, F.5
Ruhrmann, S.6
-
4
-
-
84875502025
-
Anandamide dysfunction in prodromal and established psychosis
-
Leweke FM. Anandamide dysfunction in prodromal and established psychosis. Curr Pharm Des 2012; 18: 5188-93.
-
(2012)
Curr Pharm des
, vol.18
, pp. 5188-5193
-
-
Leweke, F.M.1
-
5
-
-
0034107992
-
9- tetrahydrocannabinol-tolerant rats
-
DOI 10.1046/j.1471-4159.2000.0741627.x
-
Di Marzo V, Berrendero F, Bisogno T, Gonzalez S, Cavaliere P, Romero J, et al. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol- tolerant rats. J Neurochem 2000; 74: 1627-35. (Pubitemid 30163985)
-
(2000)
Journal of Neurochemistry
, vol.74
, Issue.4
, pp. 1627-1635
-
-
Di, M.V.1
Berrendero, F.2
Bisogno, T.3
Gonzalez, S.4
Cavaliere, P.5
Romero, J.6
Cebeira, M.7
Ramos, J.A.8
Fernandez-Ruiz, J.J.9
-
6
-
-
34447106643
-
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use
-
DOI 10.1016/j.schres.2007.04.025, PII S0920996407001909
-
Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Neatby MA, et al. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophr Res 2007; 94 : 29-36. (Pubitemid 47031599)
-
(2007)
Schizophrenia Research
, vol.94
, Issue.1-3
, pp. 29-36
-
-
Leweke, F.M.1
Giuffrida, A.2
Koethe, D.3
Schreiber, D.4
Nolden, B.M.5
Kranaster, L.6
Neatby, M.A.7
Schneider, M.8
Gerth, C.W.9
Hellmich, M.10
Klosterkotter, J.11
Piomelli, D.12
-
7
-
-
77957687873
-
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: Naturalistic study
-
Morgan CJA, Schafer G, Freeman TP, Curran HV. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. Br J Psychiatry 2010; 197: 285-90.
-
(2010)
Br J Psychiatry
, vol.197
, pp. 285-290
-
-
Morgan, C.J.A.1
Schafer, G.2
Freeman, T.P.3
Curran, H.V.4
-
9
-
-
47249126138
-
The psychotomimetic states inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis
-
Mason OJ, Morgan CJ, Stefanovic A, Curran HV. The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophr Res 2008; 103: 138-42.
-
(2008)
Schizophr Res
, vol.103
, pp. 138-142
-
-
Mason, O.J.1
Morgan, C.J.2
Stefanovic, A.3
Curran, H.V.4
-
10
-
-
58149477877
-
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum
-
Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, et al. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 2009; 34 : 759-66.
-
(2009)
Neuropsychopharmacology
, vol.34
, pp. 759-766
-
-
Bossong, M.G.1
Van Berckel, B.N.2
Boellaard, R.3
Zuurman, L.4
Schuit, R.C.5
Windhorst, A.D.6
-
11
-
-
41149130214
-
Serum endocannabinoid content is altered in females with depressive disorders: A preliminary report
-
DOI 10.1055/s-2007-993211
-
Hill MN, Miller GE, Ho WS, Gorzalka BB, Hillard CJ. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry 2008; 41: 48-53. (Pubitemid 351427522)
-
(2008)
Pharmacopsychiatry
, vol.41
, Issue.2
, pp. 48-53
-
-
Hill, M.N.1
Miller, G.E.2
Ho, W.-S.V.3
Gorzalka, B.B.4
Hillard, C.J.5
|